Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results

[ad_1] Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 7, 2023 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on…